MLC1 and atrial fibrillation: As observed for maternal plasma VL, none of the measured RhCMV-specific binding or functional antibody responses were statistically different in AF-positive versus AF-negative immunocompetent dams (Table 1 and Fig 6), including CMV-specific IgG avidity, which was previously reported to be associated with vertical transmission risk in humans [23].